Rita Balice-Gordon

CEO at Muna Therapeutics

ita brings 30 years of experience in neuroscience research, drug discovery and development from senior leadership roles in biopharma and a distinguished academic research career.

Prior to joining Muna, she led small molecule, biologics and gene therapy programs in neurologic, neurodegenerative and rare genetic diseases at Sanofi, and psychiatry and pain programs at Pfizer.

Timeline

  • CEO

    Current role

View in org chart